# Keros Therapeutics, Inc. (KROS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/KROS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 367.0K | $ -23.71M | $ -3.60M | $ 16.31M | $ 285.63M |
| 2025 | $ 249.90M | $ 89.09M | $ 108.49M | $ 16.88M | $ 303.13M |
| 2024 | $ 3.73M | $ -196.92M | $ -171.12M | $ 18.86M | $ 571.55M |
| 2023 | $ 163.3K | $ -165.42M | $ -137.29M | $ 14.44M | $ 332.21M |
| 2022 | $ 0 | $ -116.94M | $ -79.65M | $ 13.27M | $ 277.42M |
| 2021 | $ 23.89M | $ -69.83M | $ -75.09M | $ 1.09M | $ 243.17M |
| 2020 | $ 0 | $ -57.79M | $ -47.37M | $ 899.0K | $ 261.72M |
| 2019 | $ 12.91M | $ -15.92M | $ -21.00M | $ 1.28M | $ 495.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.06 |
| Liabilities / Eq | 0.09 |
| Current Ratio | 22.62 |

## Other views

- [Metrics](https://sponda.capital/en/KROS.md)
- [Charts](https://sponda.capital/en/KROS/charts.md)
- [Compare](https://sponda.capital/en/KROS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.